Clinical Trial Update: A Randomized, Double-blind, Placebo-controlled Study of ZSP1601 in Adult Subjects With Nonalcoholic Steatohepatitis (NASH) [Phase 2]

View source ↗

Summary

A Phase 2 randomized, double-blind, placebo-controlled trial of ZSP1601 in adults with Nonalcoholic Steatohepatitis (NASH); the study is currently active but no…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nonalcoholic Steatohepatitis

Drugs mentioned

• ZSP1601 (ZSP1601)

Snippet

Sponsor: Guangdong Raynovent Biotech Co., Ltd | Conditions: Nonalcoholic Steatohepatitis (NASH) | Phase 2 | Status: ACTIVE_NOT_RECRUITING